News
The Independent on MSN8h
A woman was told she had Alzheimer’s 13 years ago. Now she’s walking the width of the U.S. after reversing her illnessA woman was told she had Alzheimer’s 13 years ago. Now she’s walking the width of the U.S. after reversing her illness - US ...
The FDA expanded the uses of GE HealthCare’s Vizamyl imaging agent for highlighting the presence of beta amyloid proteins in ...
A new study led by scientists from BGI Genomics' Institute of Intelligent Medical Research (IIMR) has identified early ...
A new way of thinking about Alzheimer’s disease has yielded a discovery that could be the key to stopping the cognitive ...
Indianapolis: Eli Lilly and Company has recieved approval from the U.S. Food and Drug Administration (U.S. FDA) for a label ...
Medical Device Network on MSN4d
GE HealthCare’s PET imaging agent gains Alzheimer’s label expansionThe FDA label update boosts GE HealthCare’s Vizamyl to a market advantage despite the emergence of blood-based tests.
GlobalData on MSN3d
Eli Lilly receives FDA approval for Amyvid label updateThe US FDA has granted approval for a label update to Eli Lilly and Company's Amyvid (florbetapir F 18 injection) for use ...
WCBD News 2 on MSN4d
2 Your Health: FDA approves new blood test for diagnosing Alzheimer’sJune is Alzheimer’s and Brain Health Awareness Month. More than 7 million people have Alzheimer’s disease here in the United States. Now, a new blood test may be able to help with early diagnosis.
The label update for Amyvid adds guidance for assessing amyloid plaque levels and may help inform diagnostic and treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback